相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anticancer evaluation of methotrexate and curcumin coencapsulated niosomes against colorectal cancer cell line
Navid Mousazadeh et al.
NANOMEDICINE (2022)
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Paolo Antonetti et al.
SUPPORTIVE CARE IN CANCER (2022)
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)
Katsuko Kikuchi et al.
SUPPORTIVE CARE IN CANCER (2022)
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3
Laura E. Fischer et al.
BRITISH JOURNAL OF CANCER (2022)
Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location
Hitoshi Hino et al.
JOURNAL OF GASTROENTEROLOGY (2022)
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial
Alessandra Raimondi et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Apigenin and its dermatological applications: A comprehensive review
Pantea Majma Sanaye et al.
PHYTOCHEMISTRY (2022)
Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
Rossella De Luca et al.
WORLD JOURNAL OF ONCOLOGY (2021)
Vitamin E supplementation in inflammatory skin diseases
Enzo Berardesca et al.
DERMATOLOGIC THERAPY (2021)
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study
Alessandra Raimondi et al.
SUPPORTIVE CARE IN CANCER (2021)
Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial
Keita Tsutsui et al.
JOURNAL OF DERMATOLOGY (2021)
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
Davide Ciardiello et al.
CANCERS (2021)
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study
A. Raimondiy et al.
ESMO OPEN (2021)
Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan
Munenobu Kashiwa et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2021)
Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells
Zahra Bigdelou et al.
MOLECULAR BIOLOGY REPORTS (2020)
EGFRI-associated health-related quality of life by severity of skin toxicity in metastatic colorectal cancer patients receiving epidermal growth factor receptor inhibitor target therapy
Ting-Yu Chiang et al.
SUPPORTIVE CARE IN CANCER (2020)
Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience
Luigia Panariello et al.
CLINICAL COLORECTAL CANCER (2020)
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database.
Anna Dorothea Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Dermatological side effects of targeted antineoplastic therapies: a prospective study
Senay Agirgol et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2020)
Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides
Behrooz Johari et al.
MOLECULAR BIOLOGY REPORTS (2020)
Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)
David Tougeron et al.
ONCOIMMUNOLOGY (2020)
The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions
Samantha R. Ellis et al.
MICROORGANISMS (2019)
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Mario E. Lacouture et al.
CLINICAL COLORECTAL CANCER (2018)
Management of epidermal growth factor receptor inhibitor-associated rash: a systematic review
Jacqueline Brown et al.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY (2016)
Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)
Volker Heinemann et al.
EUROPEAN JOURNAL OF CANCER (2015)
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP
Yoshimitsu Kobayashi et al.
FUTURE ONCOLOGY (2015)
Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review
Taihao Quan et al.
GERONTOLOGY (2015)
Update on the Role of Imaging in Management of Metastatic Colorectal Cancer
Sree Harsha Tirumani et al.
RADIOGRAPHICS (2014)
Characteristics of the Aging Skin
Miranda A. Farage et al.
ADVANCES IN WOUND CARE (2013)
Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review
J. M. Baas et al.
CANCER TREATMENT REVIEWS (2012)
Targeted-Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Amalia Milano et al.
REVIEWS ON RECENT CLINICAL TRIALS (2011)
Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer
Mario E. Lacouture et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
JP Spano et al.
ANNALS OF ONCOLOGY (2005)